Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James V. Fiorica, MD
Sarasota Memorial Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Birmingham, Alabama, United States
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- Kaiser Permanente Medical Center - Los Angeles
Los Angeles, California, United States
- Olive View - Ucla Medical Center Foundation
Sylmar, California, United States
- Helen and Harry Gray Cancer Center at Hartford Hospital
Hartford, Connecticut, United States
- George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
New Britain, Connecticut, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Lakeland Regional Cancer Center at Lakeland Regional Medical Center
Lakeland, Florida, United States
- Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
Savannah, Georgia, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- William Beaumont Hospital - Royal Oak Campus
Royal Oak, Michigan, United States
- University of Mississippi Cancer Clinic
Jackson, Mississippi, United States
- Regional Cancer Center at Singing River Hospital
Pascagoula, Mississippi, United States
- Saint Louis University Cancer Center
St Louis, Missouri, United States
- Methodist Estabrook Cancer Center
Omaha, Nebraska, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, United States
- Mount Carmel Health - West Hospital
Columbus, Ohio, United States
- Riverside Methodist Hospital Cancer Care
Columbus, Ohio, United States
- David L. Rike Cancer Center at Miami Valley Hospital
Dayton, Ohio, United States
- Oklahoma University Cancer Institute
Oklahoma City, Oklahoma, United States
- Cancer Care Associates - Midtown Tulsa
Tulsa, Oklahoma, United States
- Women and Infants Hospital of Rhode Island
Providence, Rhode Island, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2005
- Primary completion
- 31 Jan 2010
- Completion
- —
- Last update posted
- 8 Jan 2019
- Registered enrollment
- 27
- Registry id
- NCT00087126
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.